Methyl protodioscin T3771
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Methyl protodioscin potentially increase HDL cholesterol while reducing LDL cholesterol and triglycerides. Methyl protodioscin has antitumor property. Methyl protodioscin induced apoptotic process in human A549 cells is closely associated with Mitochondri
CAS nr:
54522-52-0
Purity:
98%
Molecular Weight:
1063,23
SMILES:
[C@H]1([C@@H]([C@@H]([C@H]([C@@H](O1)O[C@@H]1CC2=CC[C@H]3[C@@H]4C[C@@H]5O[C@@]([C@H]([C@@H]5[C@]4(CC[C@@H]3[C@]2(CC1)C)C)C)(CC[C@H](CO[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O)C)OC)O[C@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)C)O)O)O)O)O[C@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)C)O)O)O)CO
Formula:
C52H86O22
Pathway:
Apoptosis
Target:
Apoptosis
